Ligia Yukie Sassaki
Overview
Explore the profile of Ligia Yukie Sassaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferreira S, Parra R, Sassaki L, Miguel Luz Parente J, de Mello M, Chebli L, et al.
Gastroenterol Hepatol
. 2025 Feb;
:502396.
PMID: 39987969
Objective: Vedolizumab (VDZ) and infliximab (IFX) are first-line therapies for moderate-to-severe ulcerative colitis (UC). Despite their widespread use, there are no direct comparative studies, and real-world data, particularly in Latin...
2.
Rigo F, Oliveira E, Quaglio A, Moutinho B, Di Stasi L, Sassaki L
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273359
Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of proline- and glutamine-rich proteins, widely termed "gluten", in genetically susceptible individuals. CD induces an altered immune response that...
3.
de Medeiros Dutra R, Pinto F, Craveiro M, Baima J, Saad-Hossne R, Romeiro F, et al.
Medicine (Baltimore)
. 2024 Aug;
103(31):e39095.
PMID: 39093785
Rationale: Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by continuous inflammation of the colonic mucosa. Autoimmune hepatitis (AIH) is a chronic liver disease characterized by hypergammaglobulinemia, circulating...
4.
Costa M, Sassaki L, Chebli J
World J Gastroenterol
. 2024 Jul;
30(24):3022-3035.
PMID: 38983953
Managing inflammatory bowel disease (IBD) is becoming increasingly complex and personalized, considering the advent of new advanced therapies with distinct mechanisms of action. Achieving mucosal healing (MH) is a pivotal...
5.
Pinto F, de Medeiros Dutra R, Almeida L, Craveiro M, Baima J, Saad-Hossne R, et al.
Clin Exp Gastroenterol
. 2024 May;
17:165-171.
PMID: 38799766
Background: Inflammatory bowel disease (IBD) affects young adults of reproductive age, and questions related to pregnancy and breastfeeding are common in clinical practice. Most medications used to treat IBD are...
6.
Oliveira E, Quaglio A, Grillo T, Di Stasi L, Sassaki L
World J Gastroenterol
. 2024 May;
30(16):2184-2190.
PMID: 38690020
MicroRNAs (miRNAs), small non-coding RNAs composed of 18-24 nucleotides, are potent regulators of gene expression, contributing to the regulation of more than 30% of protein-coding genes. Considering that miRNAs are...
7.
Magro D, Sassaki L, Chebli J
World J Gastroenterol
. 2024 Apr;
30(12):1644-1650.
PMID: 38617734
In this editorial, we comment on the article by Marangoni , published in the recent issue of the 2023; 29: 5618-5629, about "Diet as an epigenetic factor in inflammatory bowel...
8.
de Barros J, Alencar R, Saad-Hossne R, Sassaki L
Gastroenterol Nurs
. 2024 Apr;
47(2):92-100.
PMID: 38567852
This study aims to develop and validate a nursing assessment tool for patients with inflammatory bowel disease. In this cross-sectional descriptive study using a quantitative approach, nurses were invited to...
9.
de Sa Brito Froes R, Andrade A, Faria M, de Souza H, Parra R, Zaltman C, et al.
Sci Rep
. 2024 Feb;
14(1):4314.
PMID: 38383742
The Brazilian Organization for Crohn's Disease and Colitis (GEDIIB) established a national registry of inflammatory bowel disease (IBD). The aim of the study was to identify clinical factors associated with...
10.
de Barros J, Ramdeen M, Rivera-Sequeiros A, Baima J, Saad-Hossne R, Alencar R, et al.
Arq Gastroenterol
. 2023 Oct;
60(3):300-308.
PMID: 37792758
•An identification of the profile of inflammatory bowel disease nurses in Brazil was peformed, and only four nurses worked exclusively with patients with inflammatory bowel disease. •The main areas of...